Use of the GnRH analogue, deslorelin acetate, in a slow-release implant to accelerate ovulation in oestrous mares.

In two separate controlled clinical trials, the efficacy and safety of 2.2 mg of the GnRH analogue deslorelin, administered subcutaneously as a short-term implant to normally cycling mares in oestrus with a dominant ovarian follicle more than 30 mm in diameter, were evaluated, using a placebo as a negative control. The oestrous cycle of each mare was followed by teasing, palpation per rectum and transrectal ultrasonography. Follicles were monitored every 24 hours by ultrasonography until ovulation occurred. The mares were either mated naturally or inseminated artificially. In trial 1, 174 mares were treated at six locations in Canada, and in trial 2, 98 mares were treated at three locations in the USA. In trial 1, the treatment with deslorelin reduced the mean (sd) time to ovulation from 84.2 (48.4) hours to 50.2 (19.6) hours (P < 0.001) and in trial 2 it reduced it from 88.8 (40.3) hours to 54.1 (26.5) hours (P < 0.001). In trial 1, the percentage of mares ovulating within 48 hours increased from 37.7 per cent in control mares to 86.1 per cent in treated mares (P < 0.001) and in trial 2 the percentage increased from 26.5 to 80.9 per cent (P < 0.001). In trial 2, the duration of oestrus in the deslorelin-treated mares was reduced from 6.1 days to 4.3 days and the number of matings or artificial inseminations was reduced from 2.5 to 1.7 (P < 0.001). In trial 1, days 12 to 20 pregnancy rates for matings at the treatment oestrus were not different for deslorelin-treated (75.6 per cent) and placebo-treated (66.1 per cent) mares. In trial 2, days 12 to 20 pregnancy rates from matings at the treatment oestrus were lower for deslorelin-treated (58.7 per cent) than for placebo-treated (83.3 per cent) mares (P < 0.05), although pregnancy rates were similar for deslorelin-treated (97.1 per cent) and placebo-treated (95.0 per cent) mares after mating at the second oestrus. In both trials, pregnancy losses due to early or late abortions were within the normally expected range and similar for deslorelin-treated (3.6 and 3.7 per cent, respectively) and placebo-treated (13.4 and 7.5 per cent) mares. The treatments did not cause systemic side effects and local reactions at the implantation sites were slight and of short duration.

Training the novice stallion for artificial breeding.

Although the act of breeding is instinctive to the stallion, the use of a phantom mare and AV represent an unnatural element to this act. The use of these devices, as well as proper breeding manners and etiquette, must be taught to the stallion. The novice stallion usually learns these techniques rapidly and is quite manageable if proper restraint is used during training. Positive reinforcement for good behavior is essential. The ultimate goal in training the novice stallion is to develop an individual that will enter the breeding area with controlled enthusiasm, develop an erection and gracefully mount the phantom or mare in a quiet manner, and rapidly ejaculate into an AV.

Factors associated with failure of passive transfer of colostral antibodies in Standardbred foals.

The records of 361 Standardbred mares and their 1986 or 1987 foals were evaluated to identify factors associated with failure of passive transfer (FPT) of colostral antibodies in equine neonates. Sixty-five foals (18%) were classified as FPT based on a serum immunoglobulin concentration of less than 400 mg/dl at 24 to 36 hours of age, determined by the glutaraldehyde coagulation test. The potential association of mare- and foal-related factors with FPT were assessed by reviewing a series of multiple logistic regression models. The season in which the mare foaled and foal exam score, a subjective assessment of foal vigor, maturity, and general health, were the primary factors associated with the development of FPT. Foals with FPT were more likely (odds ratio = 3.50; 95% confidence interval = 1.81-6.68) than normal foals to require medical therapy during the first 3 months after parturition.

A negative feedback role for the ovaries of the mare on tonic LH secretion before the first ovulation of the breeding season.

Eleven anoestrous mares were assigned randomly to Group A (intact, n = 6) or Group B (ovariectomized in January, n = 5). Jugular blood samples were collected during February to April. Ovarian activity was assessed by ultrasound and ovulation was confirmed by progesterone analysis. Intact mares ovulated between 2 and 28 April. Mean diameter of the largest follicle was less than 20 mm on 17 or 18 March (Period 3), but increased to 29 mm by 31 March or 1 April (Period 4). During Periods 1 and 2 (14 or 15 February and 3 or 4 March) mean luteinizing hormone (LH) concentrations were similar in both groups. In intact mares, circulating concentrations remained low during Periods 3 and 4. In contrast, in ovariectomized mares concentrations tended to increase during Period 3, and were significantly increased by Period 4, at which time concentrations were significantly (P less than 0.05) greater in ovariectomized as opposed to intact mares. Increased concentrations of LH in ovariectomized mares during Periods 3 and 4 were associated with well defined pulsatile profiles. In contrast, pulses in intact mares remained infrequent and low in amplitude during the same time periods. The absence of LH pulses in intact mares during Periods 3 and 4 may reflect a low pulse frequency or a decrease in amplitude such that pulses escape detection. These results support the hypothesis that in intact mares, low circulating concentrations of LH during the transition into the breeding season, in part, may reflect inhibition by a factor of ovarian origin. It remains to be determined whether this apparent inhibition of LH secretion undergoes a seasonal modification in effectiveness and plays a role in regulating the annual breeding cycle of the mare.

Comparison of four screening techniques for the diagnosis of equine neonatal hypogammaglobulinemia.

Using radial immunodiffusion as a standard, 4 screening techniques for detection of failure of passive transfer in equine neonates were compared for sensitivity, specificity, positive and negative predictive values, efficiency, and cost. The techniques compared were latex agglutination test, membrane filter ELISA, dipstick ELISA, and glutaraldehyde coagulation (GC) test. Test results of 50 serum samples from foals 24 to 60 hours old revealed consistently highest accuracy in the GC test at IgG concentrations of 400 and 800 mg/dl, and lowest cost per test, using the GC test. Two hundred fifty-three serum samples from foals 24 to 60 hours old were evaluated for comparison of results of GC and radial immunodiffusion tests. Overall efficiency was 92 and 91% at serum IgG concentrations of 400 and 800 mg/dl, respectively. Under most field circumstances, the GC test would be the preferred screening test for detection of failure of passive transfer in equine neonates.